Marianela Pérez-Torres

Suggest Changes
Learn More
PURPOSE We have investigated mechanisms of acquired resistance to the HER2 antibody trastuzumab in BT-474 human breast cancer cells. EXPERIMENTAL DESIGN BT-474 xenografts established in athymic(More)
  • 1